These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 4406109

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Behavioural correlates to the dopamine D-1 and D-2 antagonists.
    Christensen AV, Arnt J, Hyttel J, Svendsen O.
    Pol J Pharmacol Pharm; 1984; 36(2-3):249-64. PubMed ID: 6147830
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
    Zharkovskiĭ AM, Matvienko OA, Nurk AM.
    Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A possible participation of gonadotropin-releasing hormone in the neuroleptic and cataleptic effect of haloperidol.
    Umathe SN, Wanjari MM, Manna SS, Jain NS.
    Neuropeptides; 2009 Jun; 43(3):251-7. PubMed ID: 19403167
    [Abstract] [Full Text] [Related]

  • 33. Differential attenuation of some effects of haloperidol in rats given scopolamine.
    Setler P, Sarau H, McKenzie G.
    Eur J Pharmacol; 1976 Sep; 39(1):117-26. PubMed ID: 986946
    [Abstract] [Full Text] [Related]

  • 34. Effects of tryptophan and valine administration on behavioral pharmacology of haloperidol.
    Ali O, Haleem DJ, Saify ZS, Kamil N, Obaid R, Ahmed SW.
    Pak J Pharm Sci; 2005 Apr; 18(2):23-8. PubMed ID: 16431394
    [Abstract] [Full Text] [Related]

  • 35. Tolerance to behavioral effects of haloperidol.
    Campbell A, Baldessarini RJ.
    Life Sci; 1981 Sep 28; 29(13):1341-6. PubMed ID: 7197320
    [No Abstract] [Full Text] [Related]

  • 36. [The influence of calcium channel blockers on the effects of haloperidol and phenamine in mice and rats].
    Kozlovskiĭ VL, Prakh'e IV, Kenunen OG.
    Eksp Klin Farmakol; 1996 Sep 28; 59(3):12-5. PubMed ID: 8974575
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
    Bartoszyk GD, Harting J, Minck KO.
    J Pharmacol Exp Ther; 1996 Jan 28; 276(1):41-8. PubMed ID: 8558454
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Pharmacological properties of substituted gamma-butyrolactones. I. The effects on the central nervous system.
    Sieroslawska J, Hano J, Sypniewska M, Czarnecki R, Chojnacka-Wójcik E, Harasiewicz A.
    Pol J Pharmacol Pharm; 1973 Jan 28; 25(1):1-16. PubMed ID: 4798097
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.